Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence
Small-molecule GLP-1RA litigation over the coming decade will likely generate more numerous, more independently contested patent challenges than peptide GLP-1RA litigation has
Plasma GHK-Cu levels start dropping measurably around age 25, the same age you begin losing roughly 1% of your collagen per year
You will be provided with a months supply of weekly injections and return to the clinic monthly for evaluation and refills
These hormones help with blood sugar and hunger
Always consult appropriate institutional guidelines and ensure protocols are approved by relevant ethical boards (e.g., IACUC, IRB)